ClinicalTrials.gg
Drug

Insulin icodec clinical trials

Also written Insulin 287.

studies test it
31
open now
2
in phase 3
11
first study started
2013

How each study uses insulin icodec is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the insulin icodec studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Mar 2026 · AWIQLI FLEXTOUCH · BLA 761326 (FDA, Drugs@FDA)
European Union
17 May 2024 · Awiqli · EMEA/H/C/005978 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Insulin icodec
28

Development codes

NNC0148-0287
1

Other names

Insulin 287
10

Studies by the year they started

30 studies that test it; most in 2021 (6); 1 more planned to start later

Studies that test insulin icodec, by start year
YearStudies
20131
20141
20161
20184
20194
20204
20216
20222
20233
20242
20252

By phase

A phase 1/2 study counts in both.

Phase 1
15
Phase 2
3
Phase 3
11
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 1

Novo Nordisk A/S (30) · Xi'an International Medical Center Hospital (1)

Often tested with

Tested in the same studies.

Semaglutide (2) · Insulin Glargine (1) · Insulin degludec (1) · NNC0148 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Insulin icodec is the comparator. A study of two new drugs counts under both.

  • 1GZR4 · Gan & Lee Pharmaceuticals. · next primary completion Nov 2026
Reaching primary completion within a year · 2, 1 in phase 3

Studies that test insulin icodec, phase 3 first.

Studies

Open first, then newest update. How each study uses insulin icodec is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 31

See all 31 studies that test insulin icodec →

Given beside what is tested · 4 — insulin icodec is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with insulin icodec

Codes

What other systems call insulin icodec · ClinicalTrials.gg INT001500

  • MeSH (NLM) C000712207insulin icodecConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) P7YU3ED05NINSULIN ICODECConfirmed FDA, NLM, Wikidata
  • Wikidata Q111982305insulin icodecConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C175800Insulin IcodecOne source FDA
  • DrugBank DB16693One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.